ArticlePolymers2026
Optimization of Bleaching Process and Evaluation of Pulp Performance for Super-Arundo Donax Kraft Pulp.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
With the increasing emphasis and protection on forest resources worldwide, the development of non-wood plant fiber raw materials has become a key path to promote the green and sustainable development of China's pulp and paper industry. In this study, Super-Arundo donax, a new non-wood fiber raw material, was systematically investigated for its applicability in the bleaching process. Firstly, by adjusting key bleaching technical variables such as alkali dosage, time, oxygen pressure and temperature, the oxygen delignification process of the Super-Arundo donax kraft pulp was optimized. The data revealed that under the experimental conditions of 3.0% alkali dosage, 60 min bleaching time, 100 °C bleaching temperature, 0.6 MPa oxygen pressure and 0.6% MgSO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.